Newborn screening for lysosomal disorders in Brazil: A pilot study using customized fluorimetric assays
Abstract Lysosomal storage disorders (LSDs) are a group of genetic disorders characterized by deficiency of specific lysosomal enzymes. In general, patients are clinically normal at birth, and progressively develop severe signs and symptoms. Diagnosis is usually made several years after onset of manifestations, preventing patients to have the benefits of the early treatment. Newborn screening programs are being considered for LSDs to allow early diagnosis and treatment. The present study evaluated the feasibility of a customized screening approach based on modified fluorometric assays with reduced amounts of reagents, substrates and samples for: mucopolysaccharidosis (MPS) type I (MPS I), MPS VI, Fabry, Gaucher, and Pompe diseases. We also evaluated the advantages of including blood chitotriosidase and urinary glycosaminoglycans in the protocol. By the measurement of the specific disease-associated enzymes (plus blood chitotriosidase and urinary glycosaminoglycans) we analyzed 834 de-identified DBS of unselected newborns. No positive case was detected, and the false-positive rates were low. Taking into consideration the limitations of this methodology, we believe that, after defining proper cutoffs, it could be a viable alternative to provide NBS for LSDs by laboratories that may not be able to afford the commercial methods available.
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Genética
2020
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572020000400107 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1415-47572020000400107 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1415-475720200004001072020-05-26Newborn screening for lysosomal disorders in Brazil: A pilot study using customized fluorimetric assaysBender,FernandaBurin,Maira G.Tirelli,Kristiane M.Medeiros,FernandaBitencourt,Fernanda Hendges deCivallero,GabrielKubaski,FrancyneBravo,HeydyDaher,AntoineCarnier,VanessaFranco,José F. S.Giugliani,Roberto Inborn errors of metabolism newborn screening enzymes Abstract Lysosomal storage disorders (LSDs) are a group of genetic disorders characterized by deficiency of specific lysosomal enzymes. In general, patients are clinically normal at birth, and progressively develop severe signs and symptoms. Diagnosis is usually made several years after onset of manifestations, preventing patients to have the benefits of the early treatment. Newborn screening programs are being considered for LSDs to allow early diagnosis and treatment. The present study evaluated the feasibility of a customized screening approach based on modified fluorometric assays with reduced amounts of reagents, substrates and samples for: mucopolysaccharidosis (MPS) type I (MPS I), MPS VI, Fabry, Gaucher, and Pompe diseases. We also evaluated the advantages of including blood chitotriosidase and urinary glycosaminoglycans in the protocol. By the measurement of the specific disease-associated enzymes (plus blood chitotriosidase and urinary glycosaminoglycans) we analyzed 834 de-identified DBS of unselected newborns. No positive case was detected, and the false-positive rates were low. Taking into consideration the limitations of this methodology, we believe that, after defining proper cutoffs, it could be a viable alternative to provide NBS for LSDs by laboratories that may not be able to afford the commercial methods available.info:eu-repo/semantics/openAccessSociedade Brasileira de GenéticaGenetics and Molecular Biology v.43 n.2 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572020000400107en10.1590/1678-4685-gmb-2018-0334 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Bender,Fernanda Burin,Maira G. Tirelli,Kristiane M. Medeiros,Fernanda Bitencourt,Fernanda Hendges de Civallero,Gabriel Kubaski,Francyne Bravo,Heydy Daher,Antoine Carnier,Vanessa Franco,José F. S. Giugliani,Roberto |
spellingShingle |
Bender,Fernanda Burin,Maira G. Tirelli,Kristiane M. Medeiros,Fernanda Bitencourt,Fernanda Hendges de Civallero,Gabriel Kubaski,Francyne Bravo,Heydy Daher,Antoine Carnier,Vanessa Franco,José F. S. Giugliani,Roberto Newborn screening for lysosomal disorders in Brazil: A pilot study using customized fluorimetric assays |
author_facet |
Bender,Fernanda Burin,Maira G. Tirelli,Kristiane M. Medeiros,Fernanda Bitencourt,Fernanda Hendges de Civallero,Gabriel Kubaski,Francyne Bravo,Heydy Daher,Antoine Carnier,Vanessa Franco,José F. S. Giugliani,Roberto |
author_sort |
Bender,Fernanda |
title |
Newborn screening for lysosomal disorders in Brazil: A pilot study using customized fluorimetric assays |
title_short |
Newborn screening for lysosomal disorders in Brazil: A pilot study using customized fluorimetric assays |
title_full |
Newborn screening for lysosomal disorders in Brazil: A pilot study using customized fluorimetric assays |
title_fullStr |
Newborn screening for lysosomal disorders in Brazil: A pilot study using customized fluorimetric assays |
title_full_unstemmed |
Newborn screening for lysosomal disorders in Brazil: A pilot study using customized fluorimetric assays |
title_sort |
newborn screening for lysosomal disorders in brazil: a pilot study using customized fluorimetric assays |
description |
Abstract Lysosomal storage disorders (LSDs) are a group of genetic disorders characterized by deficiency of specific lysosomal enzymes. In general, patients are clinically normal at birth, and progressively develop severe signs and symptoms. Diagnosis is usually made several years after onset of manifestations, preventing patients to have the benefits of the early treatment. Newborn screening programs are being considered for LSDs to allow early diagnosis and treatment. The present study evaluated the feasibility of a customized screening approach based on modified fluorometric assays with reduced amounts of reagents, substrates and samples for: mucopolysaccharidosis (MPS) type I (MPS I), MPS VI, Fabry, Gaucher, and Pompe diseases. We also evaluated the advantages of including blood chitotriosidase and urinary glycosaminoglycans in the protocol. By the measurement of the specific disease-associated enzymes (plus blood chitotriosidase and urinary glycosaminoglycans) we analyzed 834 de-identified DBS of unselected newborns. No positive case was detected, and the false-positive rates were low. Taking into consideration the limitations of this methodology, we believe that, after defining proper cutoffs, it could be a viable alternative to provide NBS for LSDs by laboratories that may not be able to afford the commercial methods available. |
publisher |
Sociedade Brasileira de Genética |
publishDate |
2020 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572020000400107 |
work_keys_str_mv |
AT benderfernanda newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays AT burinmairag newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays AT tirellikristianem newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays AT medeirosfernanda newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays AT bitencourtfernandahendgesde newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays AT civallerogabriel newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays AT kubaskifrancyne newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays AT bravoheydy newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays AT daherantoine newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays AT carniervanessa newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays AT francojosefs newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays AT giuglianiroberto newbornscreeningforlysosomaldisordersinbrazilapilotstudyusingcustomizedfluorimetricassays |
_version_ |
1756419307294687232 |